Kathleen Hurtado, RPh, Joins SciMar ONE’s Board of Advisors

Senior pharmaceutical executive and clinical research expert to advise SciMar ONE on the company’s pharmaceutical alliances and partnerships.

Kathleen Hurtado, RPh, Joins SciMar ONE’s Board of Advisors

 

ALLENTOWN, NJ, October 25, 2021 – SciMar ONE (SciMar) welcomes Kathleen Hurtado, RPh, to its Board of Advisors as pharmaceutical alliances and partnerships advisor.

In this role, Kathleen will guide SciMar’s growth and expansion by establishing connections with key pharmaceutical stakeholders and partners in support of SciMar’s proprietary Artificial Intelligence (AI) technology, the Scientific Data Engine™ (SDE).

A drug development expert and long-time healthcare senior executive, Kathleen has held leadership positions across various healthcare channels including Fortune 500 pharmaceutical companies, national academic and clinical research institutions, and national and regional hospital systems.

Formerly, Kathleen was CEO of the Health Research Association which provides clinical trial support to the University of Southern California. She was executive vice president of sales and marketing for Schering Plough’s oncology and biotech divisions, and director of operations at the American College of Surgeons Oncology Group at Duke University. She has vast startup experience as CEO and other officer positions for several US-based biotech companies. Kathleen is currently associate vice president of the Office of Research Administration for Cancer Treatment Centers of America.

Kathleen will use her expertise in clinical research administration, compliance, and regulatory management to guide SciMar’s pharmaceutical partnerships.

“The critical time between drug discovery and commercialization can be long and fraught with failures,” says Hurtado. “It’s between these two milestones where SciMar’s SDE solution is so valuable and urgently needed. The SDE helps maximize a drug’s full potential by using AI to address key activities that help reduce failures and decrease time market.”

“I am truly honored to have Kathleen join our Board of Advisors,” says Donna Conroy, SciMar founder and CEO. “I first met Kathleen at Schering Plough where she was an accomplished senior executive. She was a strong female role model at a time when few women held such important roles. I am in awe of Kathleen’s achievements and the roles she’s held across healthcare. Her broad base of experiences will certainly help the SDE succeed.”

Kathleen earned a BS in pharmacy at the University of Houston and was a pediatric oncology pharmacist at MD Anderson Cancer Center in Houston, Texas. She is affiliated with the American College of Healthcare Executives, the Board of Counselors of the University of Southern California School of Pharmacy, and the Board of Directors for Westside Family Health Center.

An active healthcare speaker, Kathleen often presents on topics including clinical trial budgeting, billing and contracting, successful negations, and building effective teams.

Kathleen resides in Texas, where she enjoys walking her dogs, reading, and spending time with family.

About SciMar ONE, Inc.: SciMar ONE, LLC is a New Jersey-based woman-owned company with deep roots in healthcare and technology.   SciMar’s  mission is to improve global healthcare by helping accelerate development of life-changing therapies. SciMar’s proprietary artificial intelligence (AI)-powered drug development platform, The Scientific Data Engine™, helps pharma accelerate drug development towards commercialization. Learn more at: https://www.scimarone.com

Media Contact:
Amy Towery
SciMar ONE, Public Relations
amy@scimarone.com

 


Leave a Reply

Your email address will not be published.